Geoffrey Slayden
Papers
1
Total Citations
14
H-Index
1
About
Dr. Geoffrey Slayden is a leading clinical researcher in hernia surgery and advanced wound management, with a focused expertise in evaluating novel biologic and synthetic mesh technologies for complex abdominal wall reconstruction. His most significant contribution is the landmark BRAVO study, a prospective, multi-center clinical trial that provided the first rigorous, long-term evidence on the performance of OviTex® 1S, a permanent reinforced tissue matrix. As the lead author of the 24-month results (14+ citations), Dr. Slayden demonstrated that this innovative material achieves durable hernia repair with low recurrence and complication rates in a challenging patient cohort. His work directly addresses the critical clinical need for improved outcomes in ventral hernia repair, offering surgeons data-driven alternatives to traditional synthetic meshes. By establishing the safety and efficacy of this novel biologic scaffold, Dr. Slayden’s research has influenced surgical practice and product development, helping to shape the standard of care for patients requiring permanent reinforcement of the abdominal wall.
Research Focus
Key Achievements
Top Papers
- 1